SCHEMBL4774517

SCHEMBL4774517

Cc1ccc(F)c(Cc2nc3c(nc(-c4ccc(Cl)cc4)n3C)c(=O)[nH]2)c1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
HPGD P15428 3/20 0.37
ALDH1A1 P00352 2/20 0.37
KDM4E B2RXH2 1/20 0.37
PKM P14618 1/20 0.37
ADORA3 P0DMS8 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
PARP1 P09874 1/20 0.33
TNKS O95271 1/20 0.33
TNKS2 Q9H2K2 1/20 0.33
PARP2 Q9UGN5 1/20 0.33
DHFR P00374 2/20 0.33
LMNA P02545 1/20 0.33
GAA P10253 1/20 0.33
RECQL P46063 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
MAPT P10636 1/20 0.33
CCNB2 O95067 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4776840 0.90 KMT2A (0.44) MEN1KMT2AHPGDALDH1A1KDM4E
SCHEMBL4777055 0.88 MEN1 (0.44) MEN1KMT2AHPGDALDH1A1KDM4E
SCHEMBL4776863 0.85 PIM1 (0.34) MEN1KMT2APARP1CCNB2CCNE2
SCHEMBL4772366 0.84 MEN1 (0.43) MEN1KMT2AHPGDALDH1A1KDM4E
SCHEMBL4772481 0.82 MEN1 (0.43) MEN1KMT2AHPGDALDH1A1KDM4E
SCHEMBL4767017 0.80 POLB (0.40) KMT2AHPGDALDH1A1KDM4EADORA3
SCHEMBL4776947 0.78 RNASEH1 (0.49) MEN1KMT2AHPGDALDH1A1KDM4E
SCHEMBL4767126 0.78 HPGD (0.39) MEN1KMT2AHPGDALDH1A1KDM4E
SCHEMBL4770146 0.78 PIM1 (0.39) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL4776202 0.77 ALDH1A1 (0.39) MEN1KMT2AHPGDALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1881988-A1 2,3-SUBSTITUTED FUSED BICYCLIC PYRIMIDIN-4(3H)-ONES MODULATING THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1) MERCK SHARP & DOHME LTD. (GB) 2008-01-30 EP disclosed
WO-2006122200-A1 2,3-SUBSTITUTED FUSED BICYCLIC PYRIMIDIN-4(3H)-ONES MODULATING THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1) MERCK SHARP & DOHME LIMITED (GB) 2006-11-16 WO disclosed